Acadia Pharmaceuticals Gains 6% on Bank of America 'Buy' Upgrade

Edgen Stock·Mar 25 2026, 19:21

Share to

Share to

Copy link

BAC+1.27%

ACAD+5.01%

Key Takeaways

Bank of America upgraded Acadia Pharmaceuticals to 'Buy' from 'Neutral' on March 25, citing an attractive risk-reward profile after a recent stock decline. The move spurred a 6% increase in the share price, with analysts attributing the preceding drop to macro factors rather than company fundamentals.

Analyst Upgrade: Bank of America raised its rating on Acadia (NASDAQ:ACAD) to 'Buy' from 'Neutral', maintaining a $29 price objective.
Market Reaction: The stock responded immediately to the news, climbing 6% to trade at $22 on Wednesday afternoon.
Investment Rationale: The upgrade was prompted by a ~25% pullback in the stock, which analysts believe created an attractive entry point unrelated to the company's core business.

Stock Climbs 6% on Bank of America 'Buy' Upgrade

Acadia Pharmaceuticals (NASDAQ:ACAD) shares gained 6% to trade at $22 on Wednesday after Bank of America upgraded the stock to 'Buy' from 'Neutral'. The investment bank maintained its $29 price objective in its March 25 note, signaling significant potential upside from the current trading level. The upgrade provided a strong catalyst for the biopharmaceutical company, sparking renewed investor interest.

Analysts See Opportunity After 25% Pullback

Bank of America's decision was triggered by a roughly 25% decline in Acadia's stock price year-to-date. Analysts at the firm stated the sell-off was "not related to fundamentals and more related to YTD macro factors," which created a more attractive risk-reward profile. This assessment suggests the market overreacted to broader economic trends, creating a buying opportunity based on the company's underlying business and what the bank referred to as its "pipeline potential."

source:

[1] Here are Wednesday's biggest analyst calls: Tesla, Amazon, General Motors, Netflix, Microsoft, Arm & more [2] Bank of America says these stocks have plenty of upside, including one Magnificent Seven name [3] Here are Wednesday's biggest analyst calls: Tesla, Amazon, General Motors, Netflix, Microsoft, Arm & more



Features

AI Copilot for Stock & Crypto

Resources